Hospital and outpatient health services utilization among HIV-infected children in care 2000-2001

被引:0
作者
Rutstein, RM
Gebo, KA
Siberry, GK
Flynn, PM
Spector, SA
Sharp, VL
Fleishman, JA
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA
[2] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA USA
[3] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN USA
[4] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA
[5] St Lukes Roosevelt Hosp, Ctr Comprehens Care, New York, NY USA
[6] Agcy Healthcare Res & Qual, Ctr Financing Access & Cost Trends, Rockville, MD USA
关键词
resource use; HIV; children; hospital admission; antiretroviral therapy;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The aging of the pediatric HIV cohort and advances in antiretroviral therapy for children may have resulted in recent changes in patterns of healthcare utilization. Objectives: The objectives of this study were to examine inpatient and outpatient HIV-related health service utilization in a multistate sample of HIV-infected children, and to assess sociodemographic and clinical correlates of utilization. Design: Cohort study of pediatric patients with HIV. Demographic, clinical, and resource utilization data were collected from medical records for 2000 and 2001. Setting: This study was conducted at 4 U.S. HIV primary pediatric and specialty care sites in different geographic regions. Patients: Three hundred three HIV-positive children with at least one outpatient visit or CD4 test in either 2000 or 2001 were studied. Main Outcome Measures: Mean outcome measures were number of hospital admissions, mean length of hospital stay, and number of outpatient clinic/office visits. Results: Hospitalization rates decreased significantly from 39.2 (95% confidence interval [CI], 28.4-50.1) to 25.3 (95% Cl, 16.4-34.3) admissions per 100 patients between 2000 and 2001. Hospitalizations were higher among patients with greater immunosuppression, those 2 years and under, and those with AIDS, but were not significantly related to receipt of highly active antiretroviral therapy. Mean outpatient visits did not change significantly between 2000 and 2001 from 9.09 (95% Cl, 8.3-9.9) to 9.06 (95% Cl, 8.4-9.7) visits per child per year. Children 2 years and under, those on highly active antiretroviral therapy, those with AIDS, and those with Medicaid had significantly higher outpatient utilization. Those with higher HIV-1 RNA had higher outpatient utilization than those with less advanced disease. Conclusion: Inpatient utilization significantly decreased between 2000 and 2001, but outpatient utilization did not change over time. Compared with prior studies, utilization rates appear to be declining over time. Unlike, adults, racial/ethnic or gender disparities in healthcare utilization are less pronounced for HIV-infected children.
引用
收藏
页码:31 / 39
页数:9
相关论文
共 33 条
[11]   Costs of HIV medical care in the era of highly active antiretroviral therapy [J].
Gebo, KA ;
Chaisson, RE ;
Folkemer, JG ;
Bartlett, JG ;
Moore, RD .
AIDS, 1999, 13 (08) :963-969
[12]   Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001 [J].
Gebo, KA ;
Fleishman, JA ;
Conviser, R ;
Reilly, ED ;
Korthuis, PT ;
Moore, RD ;
Hellinger, J ;
Keiser, P ;
Rubin, HR ;
Crane, L ;
Hellinger, FJ ;
Mathews, WC .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 38 (01) :96-103
[13]  
Gebo KA, 2001, J ACQ IMMUN DEF SYND, V27, P143, DOI 10.1097/00126334-200106010-00009
[14]   Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland [J].
Gibb, DM ;
Duong, T ;
Tookey, PA ;
Sharland, M ;
Tudor-Williams, G ;
Novelli, V ;
Butler, K ;
Riordan, A ;
Farrelly, L ;
Masters, J ;
Peckham, CS ;
Dunn, DT .
BMJ-BRITISH MEDICAL JOURNAL, 2003, 327 (7422) :1019-1023
[15]   Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1 [J].
Gortmaker, SL ;
Hughes, M ;
Cervia, J ;
Brady, M ;
Johnson, GM ;
Seage, GR ;
Song, LY ;
Dankner, WM ;
Oleske, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (21) :1522-1528
[16]   PEDIATRIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - RECENT-EVIDENCE ON THE UTILIZATION AND COSTS OF HEALTH-SERVICES [J].
HSIA, DC ;
FLEISHMAN, JA ;
EAST, JA ;
HELLINGER, FJ .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1995, 149 (05) :489-496
[17]   Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival [J].
Kitahata, MM ;
Koepsell, TD ;
Deyo, RA ;
Maxwell, CL ;
Dodge, WT ;
Wagner, EH .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) :701-706
[18]  
Kitahata MM, 2000, J ACQ IMMUN DEF SYND, V24, P106
[19]   AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy - The Swiss HIV Cohort Study [J].
Ledergerber, B ;
Erard, V ;
Weber, R ;
Hirschel, B ;
Furrer, H ;
Battegay, M ;
Vernazza, P ;
Bernasconi, E ;
Opravil, M ;
Kaufmann, D ;
Sudre, P ;
Francioli, P ;
Telenti, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (23) :2220-2226
[20]  
LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13